Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Spirox Corp. Interim / Quarterly Report 2021

Dec 23, 2021

52286_rns_2021-12-23_2c2f1b34-bae0-4c07-be6a-66bf717d9b1f.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

==> picture [720 x 13] intentionally omitted <==

==> picture [218 x 57] intentionally omitted <==

Spirox Corporation (Stock Code :3055) 2021 Third Quarter Earnings Conference

Spokesperson Noelle Ni 23 Dec 2021

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential Delivering Smarter Solutions

==> picture [720 x 13] intentionally omitted <==

Safe Harbor Notice

  • This presentation contains "forward-looking statements" and based on our own information and information from other sources we believe to be reliable. Our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward-looking statements for a variety of risk factors which are beyond our control.

  • The forward-looking statements in this presentation reflect our current expectations. About these forward-looking statements, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.

  • We didn’t expressed or implied any statement or promise, you should not place undue reliance on this presentation. The presentation does not constitute an offer of securities issuance.

==> picture [177 x 41] intentionally omitted <==

2

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

Agenda

  • Financial Review

  • 2021.4Q & 2022 Outlook

  • Q&A

==> picture [177 x 41] intentionally omitted <==

3

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

==> picture [218 x 57] intentionally omitted <==

Financial Review

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential Delivering Smarter Solutions

==> picture [720 x 13] intentionally omitted <==

Statement of Consolidated Income(QoQ)

(In NT$ Millions)

(In NT$ Millions)
ITEMS 2021.3Q
(note)
% 2021.2Q
(note)
%
2020.3Q
%
QoQ
Net Revenue 616 100 654 100
957
100
-36%
OperatingCosts (565) (92) (576) (88)
(816)
(85)
-31%
Grossprofit 51 8 78 12
141
15
-64%
Operating Expenses (189) (31) (177) (27)
(156)
(16)
21%
Other OperatingRevenue (0) (0) 0 0
0
0
Income(loss)from Operation (138) (22) (99) (15)
(15)
(2)
797%
Non-OperatingRevenue and Expenses 9 1 13 2
46
5
-81%
Income(loss)before tax (129) (21) (86) (13)
31
3
-522%
Income Tax Expenses (3) (0) 1 0
7
1
-147%
Continuingoperatingincome(loss)after tax (132) (21) (85) (13)
Discontinued operation income(loss) 9 1 (1) (0)
Net Income(loss) (123) (20) (86) (13)
37
4
-431%
Net other comprehensive income 0 0 (20) (3)
(12)
(1)
-100%
Comprehensive income (123) (20) (106) (16)
25
3
-589%
Profit attributable to:
Owners of theparent (125) (20) (87) (13)
31
3
-508%
Non-controllinginterests 2 0 1 0
6
1
-69%
EPS(NT Dollors) -1.31 -0.91 0.32
-509%
note: Theprofit and loss of the continued business and the discounted operation are shown separately

==> picture [177 x 41] intentionally omitted <==

5

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

Statement of Consolidated Income(YoY)

(In NT$ Millions)
ITEMS
2021.1Q~3Q
%
2020.1Q~3Q
% YOY
Net Revenue
1,806
100
1,549
OperatingCosts
(1,613)
(89)
(1,245)
100 17%
(80) 30%
Grossprofit
193
11
304
20 -37%
Operating Expenses
(526)
(29)
(373)
Other OperatingRevenue
3
0
(0)
(24)
(0)
41%
-4554%
Income(loss)from Operation
(331)
(18)
(69)
(4) 380%
Non-OperatingRevenue and Expenses
18
1
76
5 -77%
Income(loss)before tax
(313)
(17)
7
0 -4563%
Income Tax Expenses
(5)
(0)
6
0 -177%
Continuingoperatingincome(loss)after tax
(318)
(18)
13
1 -2465%
Discontinued operation income(loss)
4
0
(19)
(1) -123%
Net Income(loss)
(313)
(17)
(5)
(0) 5616%
Net other comprehensive income
16
1
(30)
(2) -154%
Comprehensive income
(297)
(16)
(36)
(2) 731%
Profit attributable to:
Owners of the parent
(313)
(17)
3
Non-controllinginterests
(0)
(0)
(8)
0
(1)
-10392%
-96%
EPS(NT Dollors)
-3.29
-0.03
10867%
note: The profit and loss of the continued business and the discounted operation are shown separately

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential 6

==> picture [720 x 13] intentionally omitted <==

Consolidated Balance Sheet

Items
2021.3Q
% 2021.2Q
%
2020.3Q
%
Cash and Financial Assets-current
1,178
19 1,036
17
920
19
Accounts Receivable
834
13 823
14
1,301
27
Inventories
192
3 180
3
278
6
Current Assets in Discontinued Operations
held for Sale
1,801
29 1,617
27
-
-
Other current assets
192
3 210
4
985
20
Total current assets
4,195
66 3,865
65
3,484
71
Property, plant and equipment
1,363
22 1,313
22
1,142
23
Non-current assets
2,120
34 2,096
35
1,391
29
Total assets
6,316
100 5,961
100
4,875
100
Short-term debts
1,145
18 1,049
18
1,627
33
Accounts payable
468
7 494
8
436
9
Current Liabilities in Discontinued Operations
held for Sale
1,517
24 -
-
-
-
Other current liabilities
423
7 1,729
29
253
5
Total current liabilities)
3,554
56 3,271
55
2,316
48
Long-term liabilities
530
8 488
8
207
4
Total Liabilities
4,084
65 3,759
63
2,523
52
Common Stock
1,024
16 1,024
17
1,024
21
Additional Paid-In Capital
230
4 250
4
239
5
Retained Earnings
1,270
20 1,394
23
1,623
33
Other Equity + Treasury Stock
566
-
9
-
566
-
9
-
614
-
13
-
Equity in Discontinued Operations held for
Sale
5
0 5
0
-
-
Stockholders’ equity
1,964
31 2,107
35
2,272
47
Minority interest
268
4 96
2
80
2
Total Liabilities and Stockholders’ equity
6,316
100 5,961
100
4,875
100
Spirox Confident

7

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

Consolidated Cash Flow Highlights & Financial Ratio

Items
2021.3Q
Items
2021.3Q
2021.2Q 2021.2Q 2020.3Q
Debts ratio
65%
Current Ratio
118%
Quick Ratio
108%
Accounts Receivable turnover days
121
Inventory turnover days
30
Accounts Payable turnover days)
75
63%
118%
107%
119
29
141
52%
150%
128%
112
37
51
ROA
-2.2%
-1.4% 0.8%
ROE*
-6.5%
-3.9% 1.6%
Consolidated Cash Flow
(In NT$ Milloins)
2021.3Q
QoQ
2021.2Q
YoY
2020.3Q
EBITDA
74
-
-185%
Cash Flow from Operation
227
-
-358%
*By quaterly for above indications
43
-
-230%
88
6%
88
127
-

==> picture [177 x 41] intentionally omitted <==

8

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

Consolidated Revenue Status: 2021.1-9 v.s.2020.1-9

(In NT$ Millions)
ITEMS 2021.11 % 2021.10 % 2021.10-11 % 2021.1-11 % 2021.1-9 %
Spirox-Distrbutor 176 36% 96 27% 271 32% 1,766 42% 1,495 45%
VESP Technology 70 14% 56 16% 126 15% 398 9% 272 8%
小計 245 50% 152 43% 397 47% 2,164 51% 1,767 53%
New Subsidiaries:
Maximo Enterprise 239 49% 196 55% 435 51% 1,984 47% 1,549 46%
Jetek Technology 8 2% 6 2% 14 2% 54 1% 40 1%
Consolidated Net Revenue 492 100% 354 100% 846 100% 4201 100% 3,355 100%
(In NT$ Millions)
ITEMS 2020.11 % 2020.10 % 2020.10-11 % 2020.1-11 % 2020.1-9 %
Spirox-Distrbutor 160 34% 77 36% 237 35% 1,173 39% 936 42%
VESP Technology 22 0% 26 0% 49 0% 611 20% 562 25%
小計 182 34% 103 36% 286 35% 1,783 59% 1,498 68%
New Subsidiaries:
Maximo Enterprise 329 65% 193 63% 522 64% 1,185 39% 663 30%
Jetek Technology 5 1% 2 1% 7 1% 59 2% 52 2%
Consolidated Net Revenue 516 100% 298 100% 815 100% 3,027 100% 2,212 100%
※VESP Technology:VESP(TW+CN)+DSD Division of Spirox-Shanghai

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

Consolidated Revenue Status as of 2021.11 v.s.2021.9

(In NT$ Millions)
2021.1-11 2021.1-9
Consolidated Net % Consolidated Net %
Revenue Revenue
Spirox-Distrbutor 1,766 42% Spirox-Distrbutor 1,495 45%
VESP Technology 398 9% VESP Technology 272 8%
Maximo Enterprise 1,984 47% Maximo Enterprise 1,549 46%
Jetek Technology 54 1% Jetek Technology 40 1%
TOTAL 4,201 100% TOTAL 3,355 100%

==> picture [654 x 259] intentionally omitted <==

----- Start of picture text -----

TOTAL 4,201 100% TOTAL 3,355 100%
2021.1-11 Consolidated Net Revenue 2021.1-9 Consolidated Net Revenue
Spirox-Distrbutor VESP Technology Spirox-Distrbutor VESP Technology
Maximo Enterprise Jetek Technology Maximo Enterprise Jetek Technology
1% 1%
42% 45%
47% 46%
10% 8%
----- End of picture text -----

==> picture [177 x 41] intentionally omitted <==

10

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

==> picture [218 x 57] intentionally omitted <==

2021.4Q & 2022 Outlook

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential Delivering Smarter Solutions

==> picture [720 x 13] intentionally omitted <==

2021.4Q & 2022 Outlook: Semiconductor Equipment Distribution

  • Revenue generated from Semiconductor equipment distribution has approx. 20% growth compare to which in 2020.

  • The strong market demand of 5G, IoT, LCDD, and etc. driven by COVID-19 stay-at-home economy and China local made chip policy have made tight semiconductor production capacity in fabless and OSATs. Semiconductor equipment market is increasing accordingly.

  • Stable and repeat orders of Spirox Test Solutions, including ATE, prober, and interfaces in 2021. Market share and install base in key customers are growing. Nevertheless, shipments have been lightly impacted due to the shortage of raw materials.

  • With high competitiveness in product technology, Spirox Process & Quality Assurance Solutions have major progress in installation in key accounts. Its great business potential for the future is foreseeable.

==> picture [177 x 41] intentionally omitted <==

12

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

2021.4Q & 2022 Outlook: Subsidiaries & Investment

• VESP Technology (Hefei):

  • ⎻ Established the U.S. Representative in CA, and will serve local customers in Silicon Valley by providing verification services back in TW.

  • ⎻ Due to huge amount of CAPEX depreciation, 2021 profit of VESP is much lower than expected. We’ve reviewed capital expenditure and business operation planning, and will increase the loading rate of invested equipment accordingly. In addition, VESP will look for cooperation with local labs or industrial association to expand capacity in other cities in China.

• Jetek Technology (Taiwan):

  • ⎻ Keep developing CIS solution to generate revenue and profit in 2022 expectedly.

  • ⎻ Cooperation with Molsentech on COVID-19 Rapid Test System, which is in application process for EUA in Taiwan and other countries. Meanwhile, Jetek is also in preparation for mass production in 1H 2022.

  • MAXIMO (Shanghai): Approved by the Board of Directors, MAXIMO (Shanghai) will be disposed.

==> picture [177 x 41] intentionally omitted <==

13

Spirox Confidential

==> picture [720 x 13] intentionally omitted <==

==> picture [218 x 57] intentionally omitted <==

Thank You !

==> picture [177 x 41] intentionally omitted <==

Spirox Confidential Delivering Smarter Solutions